Ken Griffin's position in Day One Biopharmaceuticals is currently worth $764 Thousand. That's 0.00% of their equity portfolio (3137th largest holding). The first Day One Biopharmaceuticals trade was made in Q1 2022. Since then Ken Griffin bought shares four more times and sold shares on four occasions. The stake costed the investor $751 Thousand, netting the investor a gain of 1.7% so far.